ClinVar Miner

Submissions for variant NM_025077.4(TOE1):c.-38G>C

gnomAD frequency: 0.00001  dbSNP: rs774530388
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000766680 SCV000293298 uncertain significance not provided 2021-08-16 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (Lek 2016); Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000237070 SCV000601647 uncertain significance not specified 2017-01-25 criteria provided, single submitter clinical testing
Ambry Genetics RCV001020693 SCV001182203 uncertain significance Hereditary cancer-predisposing syndrome 2017-11-29 criteria provided, single submitter clinical testing The c.36+4C>G intronic variant results from a C to G substitution 4 nucleotides after coding exon 1 in the MUTYH gene. This nucleotide position is not well conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by BDGP to weaken the efficiency of the native splice donor site, but is not predicted to have a deleterious effect on this splice donor site by ESEfinder; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000237070 SCV001983537 uncertain significance not specified 2021-09-20 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001020693 SCV002052083 uncertain significance Hereditary cancer-predisposing syndrome 2021-02-17 criteria provided, single submitter clinical testing This variant causes a C to G nucleotide substitution at the +4 position of intron 1 of the MUTYH gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 3/249368 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Invitae RCV001857808 SCV002197222 likely benign Familial adenomatous polyposis 2 2024-01-17 criteria provided, single submitter clinical testing
Baylor Genetics RCV001857808 SCV004199425 uncertain significance Familial adenomatous polyposis 2 2022-07-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.